Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (51-60 of 508) with videos related to

Pageof 51
Sort By:
Plos One|March 17, 2016
High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD CohortAlan T Clarke, Paul C D Johnson, Gillian C Hall, et al.
European Journal of Heart Failure|June 28, 2013
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT studyLuigi Tavazzi, Karl Swedberg, Michel Komajda, et al.
European Heart Journal|October 31, 2007
Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failureRoy S Gardner, Kwok S Chong, Eileen O'Meara, et al.
European Journal of Cardiovascular Nursing|November 19, 2003
Patients' perspectives on statin therapy for treatment of hypercholesterolaemia: a qualitative studyElizabeth P Tolmie, Grace M Lindsay, Susan M Kerr, et al.
Circulation. Cardiovascular Quality and Outcomes|December 24, 2015
Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life SubstudyMichal Tendera, Olivier Chassany, Roberto Ferrari, et al.
European Journal of Heart Failure|September 18, 2015
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trialMichel Komajda, Luigi Tavazzi, Bernard G Francq, et al.
Journal of Clinical Medicine|October 14, 2022
The Role of Iron in Calciphylaxis-A Current ReviewOlivia Wickens, Sharmilee Rengarajan, Rajkumar Chinnadurai, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 22, 2017
Penumbra and re-canalization acute computed tomography in ischemic stroke evaluation: PRACTISE study protocolSalwa El-Tawil, Joanna Wardlaw, Ian Ford, et al.
Stroke|July 30, 2014
Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trialMichiel L Bots, Ian Ford, Suzanne M Lloyd, et al.
Cardiology|May 14, 2015
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT PopulationEdimar Alcides Bocchi, Michael Böhm, Jeffrey S Borer, et al.
Pageof 51

Showing results (51-60 of 508) with videos related to

Sort By:
Pageof 51
Plos One|March 17, 2016
High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD CohortAlan T Clarke, Paul C D Johnson, Gillian C Hall, et al.
European Journal of Heart Failure|June 28, 2013
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT studyLuigi Tavazzi, Karl Swedberg, Michel Komajda, et al.
European Heart Journal|October 31, 2007
Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failureRoy S Gardner, Kwok S Chong, Eileen O'Meara, et al.
European Journal of Cardiovascular Nursing|November 19, 2003
Patients' perspectives on statin therapy for treatment of hypercholesterolaemia: a qualitative studyElizabeth P Tolmie, Grace M Lindsay, Susan M Kerr, et al.
Circulation. Cardiovascular Quality and Outcomes|December 24, 2015
Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life SubstudyMichal Tendera, Olivier Chassany, Roberto Ferrari, et al.
European Journal of Heart Failure|September 18, 2015
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trialMichel Komajda, Luigi Tavazzi, Bernard G Francq, et al.
Journal of Clinical Medicine|October 14, 2022
The Role of Iron in Calciphylaxis-A Current ReviewOlivia Wickens, Sharmilee Rengarajan, Rajkumar Chinnadurai, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 22, 2017
Penumbra and re-canalization acute computed tomography in ischemic stroke evaluation: PRACTISE study protocolSalwa El-Tawil, Joanna Wardlaw, Ian Ford, et al.
Stroke|July 30, 2014
Thromboxane prostaglandin receptor antagonist and carotid atherosclerosis progression in patients with cerebrovascular disease of ischemic origin: a randomized controlled trialMichiel L Bots, Ian Ford, Suzanne M Lloyd, et al.
Cardiology|May 14, 2015
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT PopulationEdimar Alcides Bocchi, Michael Böhm, Jeffrey S Borer, et al.
Pageof 51